ArticleEClinicalMedicine2024

12-month neurological and psychiatric outcomes of semaglutide use for type 2 diabetes: a propensity-score matched cohort study.

Riccardo De Giorgi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.